These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 38753981)

  • 1. Investigating the relationship between changes in metaphysical beliefs and death anxiety following a significant psychedelic experience.
    Moreton SG; Barr NN; Giese KJ
    Death Stud; 2024 May; ():1-10. PubMed ID: 38753981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics alter metaphysical beliefs.
    Timmermann C; Kettner H; Letheby C; Roseman L; Rosas FE; Carhart-Harris RL
    Sci Rep; 2021 Nov; 11(1):22166. PubMed ID: 34815421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endorsement of metaphysical idealism mediates a link between past use of psychedelics and wellbeing.
    Jylkkä J; Krabbe A; Jern P
    Sci Rep; 2024 Jun; 14(1):13276. PubMed ID: 38858435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes.
    Acevedo EC; Uhler S; White KP; Al-Shawaf L
    J Psychoactive Drugs; 2024 Feb; ():1-10. PubMed ID: 38341606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychedelic Experiences Increase Mind Perception but do not Change Atheist-Believer Status: A Prospective Longitudinal Study.
    Nayak SM; White SH; Hilbert SN; Lowe MX; Jackson H; Griffiths RR; Garcia-Romeu A; Yaden DB
    J Psychoactive Drugs; 2024 May; ():1-10. PubMed ID: 38715376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.
    Sweeney MM; Nayak S; Hurwitz ES; Mitchell LN; Swift TC; Griffiths RR
    PLoS One; 2022; 17(8):e0271926. PubMed ID: 36001643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowing and being known: Psychedelic-assisted psychotherapy and the sense of authenticity.
    Fischman LG
    Front Psychiatry; 2022; 13():933495. PubMed ID: 36203843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced death anxiety as a mediator of the relationship between acute subjective effects of psychedelics and improved subjective well-being.
    Moreton SG; Arena AFA; Foy Y; Menzies RE
    Death Stud; 2023; 47(10):1115-1126. PubMed ID: 36729996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Belief changes associated with psychedelic use.
    Nayak SM; Singh M; Yaden DB; Griffiths RR
    J Psychopharmacol; 2023 Jan; 37(1):80-92. PubMed ID: 36317643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Single Belief-Changing Psychedelic Experience Is Associated With Increased Attribution of Consciousness to Living and Non-living Entities.
    Nayak SM; Griffiths RR
    Front Psychol; 2022; 13():852248. PubMed ID: 35418909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.
    Williams MT; Davis AK; Xin Y; Sepeda ND; Grigas PC; Sinnott S; Haeny AM
    Drugs (Abingdon Engl); 2021; 28(3):215-226. PubMed ID: 34349358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the need for metaphysics in psychedelic therapy and research.
    Sjöstedt-Hughes P
    Front Psychol; 2023; 14():1128589. PubMed ID: 37063525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).
    Nour MM; Evans L; Nutt D; Carhart-Harris RL
    Front Hum Neurosci; 2016; 10():269. PubMed ID: 27378878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtypes of the psychedelic experience have reproducible and predictable effects on depression and anxiety symptoms.
    Nikolaidis A; Lancelotta R; Gukasyan N; Griffiths RR; Barrett FS; Davis AK
    J Affect Disord; 2023 Mar; 324():239-249. PubMed ID: 36584715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample.
    Nygart VA; Pommerencke LM; Haijen E; Kettner H; Kaelen M; Mortensen EL; Nutt DJ; Carhart-Harris RL; Erritzoe D
    J Psychopharmacol; 2022 Aug; 36(8):932-942. PubMed ID: 35924888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.
    Raison CL; Jain R; Penn AD; Cole SP; Jain S
    Front Psychiatry; 2022; 13():831092. PubMed ID: 35370864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative beliefs in psychedelic drug users.
    Lebedev AV; Acar K; Horntvedt O; Cabrera AE; Simonsson O; Osika W; Ingvar M; Petrovic P
    Sci Rep; 2023 Sep; 13(1):16432. PubMed ID: 37777572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychedelics, Personality and Political Perspectives.
    Nour MM; Evans L; Carhart-Harris RL
    J Psychoactive Drugs; 2017; 49(3):182-191. PubMed ID: 28443703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample.
    Mans K; Kettner H; Erritzoe D; Haijen ECHM; Kaelen M; Carhart-Harris RL
    Front Psychiatry; 2021; 12():647909. PubMed ID: 34267683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.
    Moreton SG; Szalla L; Menzies RE; Arena AF
    Psychopharmacology (Berl); 2020 Jan; 237(1):21-32. PubMed ID: 31784805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.